DEEPLIFE
- Biotech or pharma, therapeutic R&D
DeepLife is a pioneering biotech company transforming drug development through artificial intelligence and digital twin technology. Our end-to-end drug repurposing platform leverages an AI-driven engine that maps cell-type specific networks, utilizing over 100 million harmonized single-cell omics data points to help researchers identify drug targets, explore intricate gene/protein interactions, and analyze complex regulatory networks with unprecedented precision.
Our innovative approach focuses on target identification and drug repurposing, dramatically accelerating timelines by identifying new therapeutic applications for FDA-approved drugs and molecules with established safety profiles. By employing sophisticated computational models integrated with multi-omics analytics, we pinpoint critical targets and biomarkers capable of reverting diseased cells to healthy states. Our primary research domains concentrate on autoimmune disorders and neurodegenerative diseases.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}